title: Ovarian metastasis in carcinoma of the uterine cervix.
abstract: BACKGROUND
  The present study was conducted to determine the frequency and clinicopathological features of ovarian metastasis in a large population of patients with stage Ib-IIb cervical cancer.
  
  
  METHODS
  The study population consisted of 3471 patients with stage Ib to IIb cervical cancer who underwent radical hysterectomy, including pelvic lymphadenectomy and bilateral salpingo-oophorectomy, at our six institutions between 1981 and 2000. To our knowledge, this study is the largest review of patients with ovarian metastasis from cervical cancer. We reviewed the patients' medical records to determine clinicopathological features.
  
  
  RESULTS
  Fifty-two patients (1.50%) had ovarian metastases: 6 in stage Ib1, 12 in stage Ib2, 5 in stage IIa, and 29 in stage IIb. The mean age of patients with ovarian metastasis was 49.9 years (range: 29-73 years). The incidence of ovarian metastasis in patients with cervical cancer was 0.22% for stage Ib, 0.75% for stage IIa, and 2.17% for stage IIb with squamous cell carcinoma, and 3.72%, 5.26%, and 9.85%, respectively, in adenocarcinoma. Ovarian metastasis occurred more frequently among patients with adenocarcinoma than among those with squamous cell carcinoma (5.31% vs. 0.79%). Outcome for patients with ovarian metastasis was very poor and not related to FIGO stage and histological type. The presence of ovarian metastasis did not correlate with lymph node involvement or parametrial invasion.
  
  
  CONCLUSIONS
  Study results indicate that ovaries can be preserved in patients with stage Ib-IIa squamous cell carcinoma but removed in all patients with adenocarcinoma.
authors.affiliation: Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi Yonago 683-8504, Japan.
authors.forename: Muneaki
authors.initials: M
authors.lastname: Shimada
authors.forename: Junzo
authors.initials: J
authors.lastname: Kigawa
authors.forename: Ryuichiro
authors.initials: R
authors.lastname: Nishimura
authors.forename: Satoshi
authors.initials: S
authors.lastname: Yamaguchi
authors.forename: Kazuo
authors.initials: K
authors.lastname: Kuzuya
authors.forename: Toru
authors.initials: T
authors.lastname: Nakanishi
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Suzuki
authors.forename: Tsunekazu
authors.initials: T
authors.lastname: Kita
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Iwasaka
authors.forename: Naoki
authors.initials: N
authors.lastname: Terakawa
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000556:secondary*; D010052:Ovariectomy; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000601:surgery